USRE43371EExpiredUtilityPatentIndex 45

Use of selected cyclosporins for the treatment of hepatitis C infection

Assignee: SCALFARO PIETROPriority: Oct 1, 2004Filed: Oct 29, 2010Granted: May 8, 2012

Est. expiryOct 1, 2024(expired)· nominal 20-yr term from priority

Inventors:SCALFARO PIETRO DUMONT JEAN-MAURICE VUAGNIAUX GREGOIRE MAUVERNAY ROLLAND-YVES

A61P 31/14A61P 43/00A61P 31/00A61P 1/16C07K 7/645A61K 38/13A61K 2300/00A61K 38/21

PatentIndex Score

Cited by

References

Claims

Abstract

This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.

Claims

exact text as granted — not AI-modified

1. A method of treating hepatitis C infection in a subject comprising administering to the subject an effective amount of [D-MeAla]3-[EtVal]4-CsA.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.